688108.SH
Sino Medical Sciences Technology, Inc.
SSE · Healthcare · Medical - Devices · CN
CNY 13.42
+2.21%Oct 30, 2026, 09:30 UTC
Sino Medical Sciences Technology reported 2026 first-three-quarter revenue of RMB 450 million, up 23.66% year over year, and net profit attributable to shareholders of RMB 69.1452 million, up 227.42%.
Source:Oct 9, 2026, 11:34 UTC
Colombia's National Food and Drug Surveillance Institute approved a registration certificate for Sino Medical Sciences Technology's SC HONKYTONK coronary balloon dilatation catheter.
Source:Sep 10, 2026, 00:17 UTC
China's National Medical Products Administration confirmed that Lantval, a sutureless aortic valve replacement system jointly developed by Cardio Health Medical and Fuwai Hospital, entered the special review procedure for innovative medical devices.
Source:Sep 1, 2026, 10:35 UTC
Shenzhen Sineuro Medical Technology Co., Ltd., a subsidiary of Sinomed, received a Class III medical device registration certificate from China's National Medical Products Administration for its delivery-type balloon dilation catheter, valid until August 30, 2031.
Source:Aug 26, 2026, 11:19 UTC
Sainuomed announced its 2026 first-half results: net profit attributable to shareholders was 50.3265 million yuan, up 263.59% year-on-year.